Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease
AUTOR(ES)
Horrocks, P. M.
RESUMO
The effects of slow withdrawal of anticholinergic medication and addition of benzhexol (8 mg/day) have been studied in patients with Parkinson's disease on stable levodopa therapy. Withdrawal of anticholinergic drugs led to measurable and often severe deterioration in about two-thirds of patients. Addition of benzhexol produced a slight but definite additional improvement in those patients in whom anticholinergics were withdrawn before the trial. Anticholinergic drugs thus still have a part to play in the treatment of Parkinson's disease, for they produce benefit in addition to that provided by levodopa.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1083593Documentos Relacionados
- Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease
- Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment.
- Bromocriptine treatment in Parkinson's disease.
- Treatment of Parkinson's disease.
- Parkinson's Disease. Biochemistry, Clinical Pathology, and Treatment
